InvestorsHub Logo
Followers 20
Posts 5349
Boards Moderated 0
Alias Born 01/04/2012

Re: silvr_surfr post# 13805

Friday, 05/13/2022 4:06:53 AM

Friday, May 13, 2022 4:06:53 AM

Post# of 14905
Silvr, Organon could be where Libigel lands, when looking at HSDD, it makes sense, but when looking at its cardiovascular event and breast cancer event reducing capabilities, Merck is a better fit.

Women's health did move to Organon. It is possible that the person responsible for web page maintenance forgot to remove the box.

Interesting info on Organon and MillporeSigma.

Still hard to believe, with Dr. Snabes' intimate knowledge of Libigel, that AbbVie doesn't have a stake in it as well.

I guess we will find out soon enough.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News